Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · IEX Real-Time Price · USD
-0.41 (-5.73%)
Jun 20, 2024, 2:32 PM EDT - Market open

Burning Rock Biotech Revenue

Burning Rock Biotech had revenue of $72.30M in the twelve months ending March 31, 2024, down -12.90% year-over-year. Revenue in the quarter ending March 31, 2024 was $17.45M, a -15.89% decrease year-over-year. In the year 2023, Burning Rock Biotech had annual revenue of $75.80M, a decrease of -6.20%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
58.22M USD

Revenue Chart

* The company reports in CNY currency but revenue data is shown in USD.


Fiscal Year End Revenue Change Growth
Dec 31, 202375.80M-5.01M-6.20%
Dec 31, 202280.81M1.46M1.83%
Dec 31, 202179.35M13.62M20.72%
Dec 31, 202065.73M11.21M20.56%
Dec 31, 201954.53M24.30M80.39%
Dec 31, 201830.23M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MDxHealth 75.33M
Precision BioSciences 57.53M
MSP Recovery 9.71M
T2 Biosystems 7.18M
Revenue Rankings